195 results on '"Garrigue, Isabelle"'
Search Results
2. Antiherpetic drugs: a potential way to prevent Alzheimer’s disease?
3. Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial
4. Epidemiological and clinical insights into the enterovirus D68 upsurge in Europe 2021/22 and the emergence of novel B3-derived lineages, ENPEN multicentre study
5. Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2)
6. Herpes simplex virus, early neuroimaging markers and incidence of Alzheimer’s disease
7. Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004 and 2017.
8. Trends in epidemiology and risk factors of opportunistic infections in kidney transplant recipients between 2004-2022
9. First clinical description of letermovir resistance mutation in cytomegalovirus UL51 gene and potential impact on the terminase complex structure
10. Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)
11. Common Features of γδ T Cells and CD8 + αβ T Cells Responding to Human Cytomegalovirus Infection in Kidney Transplant Recipients
12. mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation
13. Anti‐herpetic drugs: A potential way to prevent Alzheimer’s disease?
14. Predictive Value of Provirus Load and DNA Human Immunodeficiency Virus Genotype for Successful Abacavir-Based Simplified Therapy
15. New Molecular Assays to Predict Occurrence of Cytomegalovirus Disease in Renal Transplant Recipients
16. Chapitre 1 - Généralités sur les virus
17. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study
18. Long-term expansion of effector/memory Vδ2− γδ T cells is a specific blood signature of CMV infection
19. Covichem: A biochemical severity risk score of COVID-19 upon hospital admission
20. Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients
21. Herpes simplex virus and early neuroimaging markers of Alzheimer’s disease: Hippocampal volume and white matter integrity
22. Dried cervical spots for human papillomaviruses identification
23. Novel DNA polymerase mutations conferring cytomegalovirus resistance: Input of BAC-recombinant phenotyping and 3D model
24. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma
25. HIGH INCIDENCE OF ANTI-CMV DRUG RESISTANCE AMONG D+R- KIDNEY TRANSPLANT RECIPIENTS RECEIVING PREEMPTIVE THERAPY: MO-047
26. Factors predicting the spontaneous regression of cervical high-grade squamous intraepithelial lesions (HSIL/CIN2)
27. Human papilloma viruses infection among adolescent females perinatally infected with HIV in Côte d’Ivoire
28. Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity
29. Effect of mTOR inhibitors during CMV disease in kidney transplant recipients: Results of a pilot retrospective study
30. Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer's disease
31. Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients
32. Common features of (gamma)(delta) T cells and CD8+ (alpha)(beta) T cells responding to human cytomegalovirus infection in kidney transplant recipients
33. Virologic response to nelfinavir-based regimens: pharmacokinetics and drug resistance mutations (VIRAPHAR study)
34. Genotypic drug resistance during HIV-1 primary infection in France (1996–1999): frequency and response to treatment
35. Persistence of zidovudine-resistance mutations in HIV-1 isolates from patients removed from zidovudine therapy for at least 3 years and switched to a stavudine-containing regimen
36. Cell-associated HIV-1-DNA quantitation after highly active antiretroviral therapy-treated primary infection in patients with persistently undetectable plasma HIV-1 RNA
37. Input of recombinant phenotyping for the characterization of a novel acyclovir-resistance mutation identified in a patient with recurrent herpetic keratitis
38. Different impact of rATG induction on CMV infection risk in D+R– and R+ KTRs
39. mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional ?? and ?? T cells in Kidney Transplantation
40. Foscarnet decreases HIV-1 plasma load
41. Human papilloma viruses infection among adolescent females perinatally infected with HIV in Côte d'Ivoire.
42. Characterization of a Unique γδ T-Cell Subset as a Specific Marker of Cytomegalovirus Infection Severity.
43. Targeted immunotherapy of high‑grade cervical intra‑epithelial neoplasia: Expectations from clinical trials (Review)
44. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients
45. Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants
46. Targeted immunotherapy of high-grade cervical intra-epithelial neoplasia: Expectations from clinical trials (Review).
47. O1-09-06: Herpes simplex virus, anti-herpetic medication, and dementia: Results from the three-city population-based cohort
48. Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection
49. CMV plasma DNAemia and risk of cancer among HIV-infected patients: A case–control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002–2007
50. Variability and recombination of clinical human cytomegalovirus strains from transplantation recipients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.